Abstract
The Resolute IntegrityTM drug eluting stent (DES; Medtronic) utilizes the Continuous Sinusoidal Technology. The PROPEL study is the first large, real world study to assess the safety, efficacy and deliverability of Resolute Integrity DES compared with a historical control, Xience VTM DES (Abbott
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
